November 16, 2017

Wey Education PLC Q&A: Placing & Possible Acquisition (LON:WEY)

Wey Education PLC (LON:WEY) Chairman David Massie caught up with DirectorsTalk for an exclusive interview to discuss their recent placing, a possible acquisition, further areas of marketing and when to..

Ab Dynamics PLC Q&A with CEO Tim Rogers: Final Results (LON:ABDP)

Ab Dynamics PLC (LON:ABDP) Chief Executive Officer Tim Rogers caught up with DirectorsTalk for an exclusive interview to discuss their final results, the new factory & offices, main areas of..

INTERVIEW: Falanx Group Ltd Strong Position, Clear Plan and Momentum

Falanx Group Ltd (LON:FLX) CEO & Chairman Mike Read talks to DirectorsTalk about the departure of Stuart Bladen. Mike explains the reasons for Stuarts departure, any effects this may have,..

Bluejay Mining PLC Inclusion in the MSCI World MicroCap Index

Bluejay Mining Plc ORD 0.01p, (LON:JAY) the AIM and FSE listed company with projects in Greenland and Finland, has today announced its inclusion in the Morgan Stanley Capital Index (‘MSCI’)..

Oncimmune Holdings PLC Distribution agreement signed for Iran

Oncimmune Holdings plc (LON:ONC), a leading early cancer detection company developing and commercialising its proprietary EarlyCDT® platform technology, today announces it has signed an exclusive agreement for distribution of its..

GlaxoSmithKline PLC Trelegy Ellipta EU approval for treatment of COPD

GlaxoSmithKline plc (LON:GSK) and Innoviva, Inc. (NASDAQ:INVA) today announced that the European Commission has granted marketing authorisation for Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol, ‘FF/UMEC/VI’) as a maintenance treatment in adult patients..

Search

Funds

November 16, 2017

Search

Funds

November 16, 2017

FTSE 100

Funds